Social Media gipam giovedì, febbraio 15, 2018 Social Media , Social Media 2018 Edit This analysis of the Anastrazole or Tamoxifen Alone or Combined trial of early stage estrogen receptor-positive, ERBB2-negative #BreastCancer compares the predictive value for 6 different prognostic signature tests. http://ja.ma/2BZjct7 Share on Facebook Share on Twitter Share on Google Plus RELATED POSTS I tumori mammari con mutazione dei ...Deep learning algorithms vs human p...gravidanza e rischio di sviluppo di...
0 commenti:
Posta un commento